Cargando…
The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration
Age-related macular degeneration (ARMD) is the most common cause for visual impairment in the elderly in western countries. Recently several anti-vascular endothelial growth factor (VEGF) drugs like pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin) are available for use i...
Autores principales: | Azad, Rajvardhan, Chandra, Parijat, Gupta, Ritesh |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636001/ https://www.ncbi.nlm.nih.gov/pubmed/17951901 |
Ejemplares similares
-
Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration
por: Kim, Ramasamy
Publicado: (2007) -
The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice
por: Hussain, Nazimul, et al.
Publicado: (2007) -
Pre-macular hemorrhage in chronic malaria
por: Takkar, Brijesh, et al.
Publicado: (2014) -
Role of ranibizumab in management of macular degeneration
por: Singh, Rishi P, et al.
Publicado: (2007) -
Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion
por: Azad, Rajvardhan, et al.
Publicado: (2012)